Total planned funding: $34,389,418
Clear active filters
Democratic Republic of the Congo
HTXD: Treatment: ARV Drugs
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Democratic Republic of the Congo | $34,389,418 |
Organizational Types
Private Contractor | $34,056,378 |
Own Agency | $313,924 |
Unknown | $19,116 |
NGO | $0 |
Multi-lateral Agency | $0 |
University | $0 |
FBO | $0 |
Other USG Agency | $0 |
Program Areas
Treatment | $34,389,418 |
Budget Codes
HTXD: Treatment: ARV Drugs | $34,389,418 |
Top Partner Programs
Chemonics International:
$25,173,077
Countries/Regions
Democratic Republic of the Congo
2017 | $13,616,299 |
2018 | $11,556,778 |
Partnership for Supply Chain Management:
$8,883,301
Countries/Regions
Democratic Republic of the Congo
2014 | $3,183,301 |
2015 | $5,700,000 |
USG Aggregated Agencies:
$230,582
Countries/Regions
Democratic Republic of the Congo
2015 | $45,595 |
2017 | $69,739 |
2018 | $115,248 |